phenyl acetate has been researched along with Altitude Hypoxia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banderet, LE; Cymerman, A; Fulco, CS; Kaminsky, D; Muza, SR | 1 |
| Henderson, WR; Luks, AM; Swenson, ER | 1 |
2 trial(s) available for phenyl acetate and Altitude Hypoxia
| Article | Year |
|---|---|
Cysteinyl leukotriene blockade does not prevent acute mountain sickness.
Topics: Acetates; Administration, Oral; Adult; Altitude Sickness; Analysis of Variance; Chromatography, High Pressure Liquid; Cross-Over Studies; Cyclopropanes; Cysteine; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Female; Humans; Leukotriene Antagonists; Leukotrienes; Male; Prevalence; Quinolines; Severity of Illness Index; Statistics, Nonparametric; Sulfides; Treatment Outcome | 2004 |
Leukotriene receptor blockade does not prevent acute mountain sickness induced by normobaric hypoxia.
Topics: Acclimatization; Acetates; Administration, Oral; Adult; Altitude Sickness; Atmosphere Exposure Chambers; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Female; Humans; Hypoxia; Leukotriene Antagonists; Leukotriene E4; Male; Premedication; Quinolines; Severity of Illness Index; Statistics, Nonparametric; Sulfides | 2007 |